Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30 percent.
USP15 enzyme emerges as potential target for ovarian cancer treatment
- Post author:admin
- Post published:September 24, 2026
- Post category:uncategorized
- Post comments:0 Comments